| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |